InvestSMART

Vitura Health Limited (ASX:VIT)

ALERT: Price-sensitive ASX Announcement for VIT
Current share price for VIT : $0.019 -0.012 (-38.71%)+
Release
26 Aug 2026 8:49AM
Price at Release
$0.031
Full Release
download
Summary
Vitura Health Limited's ASX Appendix 4E Preliminary Final Report for the year ended 30 June 2026 highlights a challenging financial year. The company reported a consolidated loss after tax of $4,406,176, a significant downturn from the previous year's profit of $3,061,855. This was attributed to declining average selling prices due to increased competition in the medicinal cannabis industry and higher amortisation and interest expenses. Despite a revenue increase of approximately 6%, driven by growth in medical consultation and service fees, the company's financial performance was impacted by increased sales and marketing as well as personnel expenses. The company did not declare a dividend for FY2026, following a dividend payout in September 2025. Notable financial activities included the acquisition of Livelihood Health Pty Ltd and the deconsolidation of Cortexa Pty Ltd, which contributed to changes in the group's financial position.
Key Points
  • Consolidated loss after tax of $4,406,176 for FY2026.
  • Revenues increased by approximately 6% to $131,158,015.
  • Declining average selling prices in the medicinal cannabis industry.
  • Medical consultation and service fees increased by 11%.
  • No dividend declared for FY2026.
  • Deconsolidation of Cortexa Pty Ltd resulted in a net asset impact.
  • Increased expenses in sales, marketing, and personnel.
  • Acquisition of Livelihood Health Pty Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.